A two-year follow-up of neonates with presumed sepsis treated with recombinant human granulocyte colony-stimulating factor during the first week of life
- 31 January 1996
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 128 (1) , 135-137
- https://doi.org/10.1016/s0022-3476(96)70443-2
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines.Journal of Clinical Oncology, 1994
- A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophiliaBlood, 1994
- Coordination in Low Birthweight Seven-Year-OldsActa Paediatrica, 1991
- Nonhandicapped Very-Low-Birth-Weight Infants at One Year of Age: Developmental ProfilePediatrics, 1990